Skip to main content

Table 2 Age-specific incidence rates of bacteremia for individuals previously discharged with a COPD diagnosis and reference individuals from the general population

From: Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population-a population based cohort study

COPD-patients

Control Subjects

Pathogen

N (%)1

Incidence2

N (%)1

Incidence2

HR (95% CI)3

Pooled bloodstream infections

1,265(100)

145.0 (137.2-153.2)

872 (100)

62.3 (58.3-66.5)

2.5 (2.2-2.7)

  40-59 years

157 (12.4)

87.4 (74.8-102.2)

68 (7.8)

29.1 (22.9-36.9)

3.1 (2.2-4.3)

  60-79 years

850 (67.2)

154.0 (144.0-164.7)

573 (65.7)

61.5 (56.7-66.8)

2.6 (2.3-3.0)

≥80 years

258 (20.4)

183.0 (162.0-206.8)

231 (26.5)

98.2 (86.3-111.7)

1.9 (1.5-2.3)

Staphylococcus aureus

183 (13.5)

21.0 (18.1-24.2)

127(12.8)

9.1 (7.7-10.8)

2.4(1.8-2.9)

Streptococcus pneumoniae

157 (11.2)

18.0 (15.4-21.0)

60(6.1)

4.3 (3.3-5.5)

4.1 (3.0-5.7)

Pseudomonas aeruginosa

45 (3.2)

5.2 (3.9-6.9)

26 (3.0)

1.9 (1.3-2.7)

3.0 (1.8-5.2)

Enterobacteriacea 4

985 (42.0)

112.9 (106.0-120.2)

786 (48.5)

56.2 (52.3-60.2)

2.1 (1.9-2.5)

Enterococci

94 (7.2)

10.8 (8.8-13.1)

74 (8.2)

5.3 (4.2-6.6)

1.9 (1.3-2.6)

Streptococcus pyogenes

22 (1.6)

2.5 (1.7-3.8)

15 (1.6)

1.1 (0.6-1.8)

2.8 (1.4-5.6)5

Haemophilus influenzae

10 (0.7)

1.1 (0.6-2.1)

7 (0.7)

0.5 (0.2-1-0)

2.8 (1.0-7.7)5

Moraxella catarrhalis

1

NA

0

NA

NA

  1. 1-Percentage of total blood cultures with growth in either COPD patients or control subjects. 2- Total (crude) incidence of bloodstream infections per 10,000 person-years of follow-up. Infectious episodes were separated by <30 days.3-Hazard ratio of time to first bloodstream infection estimated by Cox regression using time since inclusion as the time scale and stratified for age, year of birth and gender and adjusted for socio-economic position and co-morbidity conferring increased risk of severe bacterial infections. 4-E. coli, Citrobacter spp., Enterobacter spp., Klebsiella spp., Providencia spp., Proteus spp., Serratia marcescens.; 5-Due to the limited number of outcomes, this Cox model was only adjusted for total days spent in the hospital prior to inclusion.